Americans may end up paying more for their medicines as well as facing shortages of drugs they need. So it's possible there ...

Aping the rhetoric of Elon Musk’s Department of Government Efficiency in the US, Labour’s Health Secretary Wes Streeting ...

The approval of a new breast cancer treatment has given hope to thousands of women with an incurable form of the disease.

Critics say this violates the principle of shareholder democracy and makes it harder for investors to hold boards to account.

China’s response to new United States (U.S.) tariffs could complicate the supply of important medicines, an analysis of data ...

Although Walmart does not run supermarkets in India yet, it has tech offices in cities such as Chennai and Bengaluru. The Bengaluru office, which employs 8,000 workers, is its biggest tech hub ...

Diabetics given the pill called orforglipron lost 16 pounds, or 7.9% of their body weight, over a 40-week period.

A unit of AstraZeneca Plc is facing a new antitrust suit claiming the company monopolized the market for a blood disorder ...

AstraZeneca PLC closed 24.38% short of its 52-week high of £133.88, which the company reached on September 3rd.

With biosimilars to AstraZeneca’s blockbuster rare blood disease med Soliris recently available in the U.S., nonprofit health ...

UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports ...

Get all latest & breaking news on Hetero Drugs. Watch videos, top stories and articles on Hetero Drugs at moneycontrol.com.